Renvela
PHONETIC PRONUNCIATION: Renvela
Description
Renvela (sevelamer carbonate) is a medication that is primarily used to treat hyperphosphatemia in people with chronic kidney disease who are on dialysis. It works by binding to phosphate in the digestive tract, preventing it from being absorbed into the bloodstream. Renvela is available in tablet and powder form and can be taken with meals or snacks. Uses: Renvela is indicated for the control of serum phosphorus in adults and children 6 years of age and older with chronic kidney disease (CKD) on dialysis. Dosage: The recommended starting dose for adults is 800 mg taken with meals three times a day. The dose can be increased or decreased based on the patient's serum phosphorus level. Children who weigh less than 10 kg should not take Renvela tablets, and Renvela powder should be used instead. Demographic: Renvela is primarily prescribed for people with chronic kidney disease who are on dialysis. It is also approved for use in children aged 6 years and older. Side Effects: Common side effects of Renvela include constipation, nausea, vomiting, and diarrhea. These side effects can often be managed by adjusting the dose, taking the medication with meals or snacks, and staying hydrated. Severe allergic reactions to Renvela are rare but can occur. Interactions: Renvela can interact with other medications, including antibiotics, iron supplements, and thyroid hormone replacement therapy. Patients should inform their healthcare provider about all medications and supplements they are taking before starting Renvela. Generic Options: Sevelamer carbonate is the generic equivalent of Renvela and is available under various brand names. It is equally effective as Renvela and may be more affordable. Patients should discuss their options with their healthcare provider to determine the best treatment plan for their needs. In conclusion, Renvela is a medication that is used to control serum phosphorus levels in people with chronic kidney disease who are on dialysis. It is available in tablet and powder form and can be taken with meals or snacks. The medication has some common side effects, can interact with other medications and has a generic equivalent that may be more affordable. Patients should always discuss their treatment options with their healthcare provider to determine the best plan for their individual needs.
Faq for Renvela
Renvela (sevelamer carbonate) is a medication used to control phosphorus levels in people with chronic kidney disease who are on dialysis.
Renvela works by binding to phosphorus in the stomach and preventing its absorption into the body. This helps to lower the phosphorus levels in the blood.
The recommended starting dosage for Renvela is usually 800 mg to 1600 mg three times daily with meals. The dosage can be adjusted based on the patient's phosphorus levels.
Common side effects of Renvela may include constipation, diarrhea, stomach pain, nausea, and vomiting. It is important to talk to a healthcare provider if any severe side effects occur.
Yes, Renvela can be taken with most other medications. However, it is important to inform your doctor about all the medications you are taking to avoid any potential drug interactions.
Renvela is specifically indicated for adults and children aged 6 years and older with chronic kidney disease on dialysis. It is not recommended for use in patients who are not on dialysis.
The coverage of Renvela by insurance can vary. It is advisable to check with the specific insurance provider to determine the coverage details.
Renvela tablets should be swallowed whole and not crushed, chewed, or broken. However, the powder form of Renvela can be dissolved in water for administration if needed.
The effects of Renvela may be seen within a few weeks of starting the medication, but it may take longer for the full benefit to be realized. Regular monitoring of phosphorus levels is necessary to determine the effectiveness.
There is limited information available on the use of Renvela in pregnant or breastfeeding women. It is important to consult with a healthcare provider to assess the potential risks and benefits before using the medication.